[1] |
Bertuccio P, Alicandro G, Malvezzi M, et al. Cancer mortality in urope in 2015, and an overview of trends since 1990 [J]. Ann Oncol, 2019, 30(8): 1356-1369.
|
[2] |
Britnell M. In search of the perfect health system. london: palgrave. [M]. Macmillan Education UK, 2015: 1-248.
|
[3] |
Triggle N. NHS ranked'number one'health system [EB/OL]. (2017.7.14)[2019.12.3]
URL
|
[4] |
European association urology guidelines:prostate cancer(EAU guideline) [M]. 2019.
|
[5] |
Simmons LA, Ahmed HU, Moore CM, et al. The PICTURE study-prostate imaging (multi-parametric MRI and Prostate HistoScanning) compared to transperineal ultrasound guided biopsy for significant prostate cancer risk evaluation [J]. Contemp Clin Trials, 2014, 37(1): 69-83.
|
[6] |
Simmons LAM, Kanthabalan A, Arya M, et al. The PICTURE study: diagnostic accuracy of multiparametric MRI in men requiring a repeat prostate biopsy [J]. Br J Cancer, 2017, 116(9): 1159-1165.
|
[7] |
Simmons LAM, Kanthabalan A, ARYA M, et al. Accuracy of transperineal targeted prostate biopsies, visual estimation and image fusion in men needing repeat biopsy in the picture trial [J]. J Urol, 2018, 200(6): 1227-1234.
|
[8] |
Miah S, Eldred-evans D, Simmons LAM, et al. Patient reported outcome measures for transperineal template prostate mapping biopsies in the picture study [J]. J Urol, 2018, 200(6): 1235-1240.
|
[9] |
Simmons LAM, Kanthabalan A, Arya M, et al. Prostate Imaging Compared to Transperineal Ultrasound-guided biopsy for significant prostate cancer Risk Evaluation (PICTURE): a prospective cohort validating study assessing Prostate HistoScanning [J]. Prostate Cancer Prostatic Dis, 2019, 22(2): 261-267.
|
[10] |
Ahmed HU, EL-shater Bosaily A, Brown LC, et al. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study [J]. The Lancet, 2017, 389(10071): 815-822.
|
[11] |
Kasivisvanathan V, Rannikko AS, Borghi M, et al. MRI-targeted or standard biopsy for prostate-cancer diagnosis [J]. N Engl J Med, 2018, 378(19): 1767-1777.
|
[12] |
Moore CM, Kasivisvanathan V, Eggener S, et al. Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group [J]. Eur Urol, 2013, 64(4): 544-552.
|
[13] |
National Institute for Health and Care Excellence. Prostate cancer: diagnosis and management (NICE guideline NG131) [M]. NICE,2019.
|
[14] |
Englang N. Implementing a timed prostate cancer diagnostic pathway [EB/OL]. (2018.4)[2019.12.3].
URL
|
[15] |
Bass EJ, Freeman A, Jameson C, et al. Prostate cancer diagnostic pathway: Is a one-stop cognitive MRI targeted biopsy service a realistic goal in everyday practice? A pilot cohort in a tertiary referral centre in the UK [J]. BMJ Open, 2018, 8(10): e024941.
|
[16] |
Sridhar A, Goldstraw M, Basnett G, et al. PE38: Introduction of a "dedicated prostate surgical planning meeting" increases the frequency of nerve-sparing in men undergoing robotic prostatectomy for prostate cancer while maintaining oncological safety[J]. Eur Urol Suppl, 2014, 13(3): 29.
|
[17] |
Sugi M, Matsuda T, Yoshida T, et al. Introduction of an enhanced recovery after surgery protocol for robot-assisted laparoscopic radical prostatectomy [J]. Urol Int, 2017, 99(2): 194-200.
|
[18] |
Sridhar A N, Abozaid M, Rajan P, et al. Surgical Techniques to optimize early urinary continence recovery post robot assisted radical prostatectomy for prostate cancer [J]. Curr Urol Rep, 2017, 18(9): 71.
|
[19] |
Sooriakumaran P, Pini G, Nyberg T, et al. Erectile function and oncologic outcomes following open retropubic and robot-assisted radical prostatectomy: results from the laparoscopic prostatectomy robot open trial [J]. Eur Urol, 2018, 73(4): 618-627.
|
[20] |
Ficarra V, Novara G, Rosen R C, et al. Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy [J]. Eur Urol, 2012, 62(3): 405-417.
|